Serum and gene expression profile of cytokines in first-episode psychosis

Cited by (217)

Items 201–217 of 217

1. Childhood Trauma in Psychoses
   Ruud van Winkel, Aleksandra Lecei · 2020 · Springer eBooks
2. Microbiome-Gut-Brain Interactions in Neurodevelopmental Disorders: Focus on Autism and Schizophrenia
   Kiran V. Sandhu, Eoin Sherwin, Ted G. Dinan, John F. Cryan · 2021 · Cambridge University Press eBooks
3. Connections between social stress, immune dysregulation and psychosis
   Jacqueline Counotte · 2021
4. Cardiovascular Manifestations in Schizophrenia
   Federica Calorio, Cristina Grazia Catania, Matteo Rocchetti · 2020 · Springer eBooks
5. Investigating Stress Response across Integrated Biological Systems
   Alice A. Han · 2017
6. Cytokine Effects on Neuronal Processes and on Behavior
   Andreas Menke · 2021 · Elsevier eBooks
7. Psychosis across persons 3: Genes, biology, and neurodevelopment
   Giulia Segre, Conrad Osamede Iyegbe, Sarah Tosato, Geraldo F. Busatto, Paola Dazzan · 2023 · Oxford University Press eBooks
8. Differential effect of cannabis use and antipsychotic medication on extracellular free-water in the brain of individuals with early psychosis and controls
   Laura Martínez-Sadurní, Marta Barrera-Conde, Patricia Robledo, Emma Veza-Estévez, Jordi García-Quintana, Anna Mané, Alba Toll, Amira Trabsa, Tyler A. Lesh, Cameron S. Carter et al. · 2025 · Molecular Psychiatry
9. Natural-cause mortality and C-reactive protein levels in patients with schizophrenia spectrum disorders: A prospective total cohort study
   Farivar Fathian, I Divkovic, Maria Fagerbakke Strømme, Arnstein Mykletun, Rune A. Kroken, Christoffer Andreas Bartz-Johannessen, Erik Johnsen · 2025 · Brain Behavior & Immunity - Health
10. Chemokines and Motor Symptoms in First-Episode Psychosis: Are We Overlooking One of the Puzzle Pieces in Understanding the Neurological Immune Mechanisms behind Them?
    Alejandro Ballesteros, María Flores-López, Ana Maria Sánchez-Torres, Antonia Serrano, Eloi Giné-Servén, Ana Gavito, Fernando Rodrı́guez de Fonseca, Manuel Jesús Cuesta · 2025 · Neuropsychobiology
11. Neuro-inflammation and Serum Cytokine Levels in Schizophrenia Patients
    Ahmed Abbas Barh Aljamah, Majid Komijani · 2025 · Academia Open
12. Inflammation, infections et maladies mentales : identification de biomarqueurs et applications thérapeutiques potentielles
    Guillaume B. Fond · 2016 · theses.fr (ABES)
13. Functional immune responses to PI3K pathway inhibition in PBMCs from schizophrenia patients without metabolic syndrome
    Vivian Thaise da Silveira Anício, Ingrid Caroline Silva Dias, Érica Leandro Marciano Vieira, Salvina Maria de Campos-Carli, Cláudia Natália Ferreira, Danielle Silveira Macêdo, João Vinícius Salgado, Antônio Carlos Pinheiro de Oliveira · 2026 · Journal of Neuroimmunology
14. Effect of Add-on Yoga-Based Intervention on Schizophrenia: A Randomized Controlled Trial
    Thrinath Mullapudi, Shivarama S. Varambally, Moinak Banerjee, Ramajayam Govindaraj, Praveen Raj, Paranthaman V Kavya, Samartha Daddaladka Krishnayya, Saranya Haribabu, Kaushik Kadiwal, Girikematha S. Ravi et al. · 2026 · Behavioral Medicine
15. The role of the epidermal growth factor in the pathogenesis of schizophrenia. Clinical and diagnostic value
    Daria Piskareva, Yana Zorkina, Alisa Andryushenko, G. P. Kostyuk · 2026 · Growth Factors
16. Cytokines in First-Episode Psychosis: Implications for Pathophysiology: A Narrative Literature Review
    Lindokuhle T. Thela, Bongani Brian Nkambule, Zama N. P. Msibi, Vuyokazi Ntlantsana, Saeeda Paruk, Andrew M. Tomita, Khethelo Richman Xulu, Bonginkosi Chiliza · 2026 · Brain Sciences
17. Low‐dose LPS and acute restraint stress attenuate behavioural sensitisation in methamphetamine‐sensitised male mice
    Rikuto Christopher Shinohara, Shuhei Ishikawa, Risa Matsumoto, Koki Ito, Mariko Tonosaki, Shiina Matsuyama, Masahiro Ohgidani, Minori Koga, Naoki Hashimoto, Ichiro Kusumi et al. · 2026 · British Journal of Pharmacology